Literature DB >> 21709702

Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MI.

Peter van der Meer, Dirk J van Veldhuisen.   

Abstract

Over the past 5–10 years, the positive effects of erythropoietin on myocardial infarction have been reported in several experimental, animal models. However, the results of the REVEAL study call into question the beneficial effects of erythropoietin in humans presenting with myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21709702     DOI： 10.1038/nrcardio.2011.102

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial.

Authors:  Ilka Ott; Stefanie Schulz; Julinda Mehilli; Stefanie Fichtner; Martin Hadamitzky; Katharina Hoppe; Tareq Ibrahim; Steffan Martinoff; Steffen Massberg; Karl-Ludwig Laugwitz; Josef Dirschinger; Markus Schwaiger; Adnan Kastrati; Albert Schmig
Journal:  Circ Cardiovasc Interv       Date:  2010-08-24       Impact factor: 6.546

Review 2.  Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.

Authors:  Dirk J van Veldhuisen; Stefan D Anker; Piotr Ponikowski; Iain C Macdougall
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

3.  Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.

Authors:  Samer S Najjar; Sunil V Rao; Chiara Melloni; Subha V Raman; Thomas J Povsic; Laura Melton; Gregory W Barsness; Kristi Prather; John F Heitner; Rakhi Kilaru; Luis Gruberg; Vic Hasselblad; Adam B Greenbaum; Manesh Patel; Raymond J Kim; Mark Talan; Luigi Ferrucci; Dan L Longo; Edward G Lakatta; Robert A Harrington
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

4.  A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.

Authors:  Erik Lipsic; Peter van der Meer; Adriaan A Voors; B Daan Westenbrink; Ad F M van den Heuvel; Hetty C de Boer; Anton J van Zonneveld; Regien G Schoemaker; Wiek H van Gilst; Felix Zijlstra; Dirk J van Veldhuisen
Journal:  Cardiovasc Drugs Ther       Date:  2006-04       Impact factor: 3.727

5.  The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention.

Authors:  Jung-Won Suh; Woo-Young Chung; Yong-Seok Kim; Kwang-Il Kim; Eun-Ju Jeon; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Cheol-Ho Kim; Dong-Ju Choi
Journal:  Int J Cardiol       Date:  2010-03-02       Impact factor: 4.164

6.  A single dose of erythropoietin in ST-elevation myocardial infarction.

Authors:  Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M Ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

Review 7.  Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.

Authors:  Erik Lipsic; Regien G Schoemaker; Peter van der Meer; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

8.  Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.

Authors:  Erik Lipsic; B Daan Westenbrink; Peter van der Meer; Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst
Journal:  Eur J Heart Fail       Date:  2008-01       Impact factor: 15.534

9.  Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction.

Authors:  Azan S Binbrek; Nayan S Rao; Najib Al Khaja; Jamal Assaqqaf; Burton E Sobel
Journal:  Am J Cardiol       Date:  2009-10-15       Impact factor: 2.778

10.  Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study.

Authors:  Anho Liem; Anton P van de Woestijne; Erik Bruijns; Henk W O Roeters van Lennep; Job A J de Boo; Henk K van Halteren; Teun P van Es; J Wouter Jukema; Arnoud van der Laarse; Aeilko H Zwinderman; Dirk J van Veldhuisen
Journal:  Int J Cardiol       Date:  2007-11-01       Impact factor: 4.164
  10 in total
  2 in total

Review 1.  Signaling Pathways in Cardiac Myocyte Apoptosis.

Authors:  Peng Xia; Yuening Liu; Zhaokang Cheng
Journal:  Biomed Res Int       Date:  2016-12-22       Impact factor: 3.411

2.  Erythropoietin Attenuates Postoperative Cognitive Dysfunction by Shifting Macrophage Activation toward the M2 Phenotype.

Authors:  Jae Hoon Lee; Eun Hee Kam; So Yeon Kim; So Yeong Cheon; Eun Jung Kim; Seungsoo Chung; Ji-Hyun Jeong; Bon-Nyeo Koo
Journal:  Front Pharmacol       Date:  2017-11-16       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.